[{"AccountsPayableCurrent_0_Q3_USD":4349000.0,"OtherNonoperatingIncome_1_Q3_USD":620000.0,"OtherAssetsNoncurrent_0_Q3_USD":2036000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":225000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":3249000.0,"OperatingLeasePayments_3_Q3_USD":2428000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":1438000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":2253000.0,"OperatingLeaseLiability_0_Q3_USD":3691000.0,"OperatingLeaseCost_3_Q3_USD":1812000.0,"OperatingIncomeLoss_3_Q3_USD":-49911000.0,"OperatingIncomeLoss_1_Q3_USD":-19819000.0,"NonoperatingIncomeExpense_3_Q3_USD":2550000.0,"NonoperatingIncomeExpense_1_Q3_USD":735000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-47361000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-19084000.0,"NetIncomeLoss_3_Q3_USD":-47361000.0,"NetIncomeLoss_1_Q3_USD":-19084000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-37986000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-1286000.0,"OtherNonoperatingIncome_3_Q3_USD":1847000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-30000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":1286000.0,"PreferredStockSharesAuthorized_0_Q3_shares":9000000.0,"VariableLeaseCost_3_Q3_USD":616000.0,"SubleaseIncome_3_Q3_USD":1848000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":24000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":31000.0,"StockIssued1_3_Q3_USD":2043000.0,"StockholdersEquity_0_Q3_USD":197238000.0,"ShareBasedCompensation_3_Q3_USD":7834000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-246061000.0,"RestrictedCashNoncurrent_0_Q3_USD":1255000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":35399000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":14798000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":1341000.0,"ProfitLoss_3_Q3_USD":-47361000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":24000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_3_Q3_USD":31000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":4616000.0,"PreferredStockValue_0_Q3_USD":null,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"LiabilitiesCurrent_0_Q3_USD":16709000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":215385000.0,"Liabilities_0_Q3_USD":18147000.0,"ConvertiblePreferredStockConvertedToOtherSecurities_3_Q3_USD":25481000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-47361000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-19084000.0,"CommonStockValue_0_Q3_USD":40000.0,"CommonStockSharesOutstanding_0_Q3_shares":39851022.0,"CommonStockSharesIssued_0_Q3_shares":39851022.0,"CommonStockSharesAuthorized_0_Q3_shares":150000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-39302000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":204143000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":202888000.0,"AssetsCurrent_0_Q3_USD":207504000.0,"Assets_0_Q3_USD":215385000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":33978788.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":7834000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":3463000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":3463000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":357859000.0,"CostsAndExpenses_1_Q3_USD":19819000.0,"CostsAndExpenses_3_Q3_USD":49911000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_1_Q3_USD":100000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_3_Q3_USD":300000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":463000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":816000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":841000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":2497000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":4154000.0,"LesseeOperatingLeaseDiscountRate_0_Q3_pure":0.095,"LeaseCost_3_Q3_USD":580000.0,"InvestmentIncomeInterest_3_Q3_USD":360000.0,"InvestmentIncomeInterest_1_Q3_USD":115000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":37741526.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":1894000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":2268000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":3617000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":14512000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":5021000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":2054000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.48,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.25,"DepreciationAndAmortization_3_Q3_USD":79000.0,"DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_3_Q3_pure":1.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":2036000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":39848943.0,"Ticker":"COGT","CIK":"1622229","name":"COGENT BIOSCIENCES, INC.","OfficialName":"Cogent Biosciences Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"369716293.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211110"}]